Agonist-regulation of human β2-adrenergic receptor mRNA stability

被引:0
|
作者
Danner, S [1 ]
Frank, M [1 ]
Lohse, MJ [1 ]
机构
[1] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
189
引用
收藏
页码:R51 / R51
页数:1
相关论文
共 50 条
  • [31] Persistent agonist-mediated regulation of human β1- and β2-adrenergic receptors is subtype-specific
    Liang, W
    Hoang, Q
    Curran, PK
    Fishman, PH
    FASEB JOURNAL, 2001, 15 (04): : A217 - A217
  • [32] Moxonidine, a mixed α2-adrenergic and imidazoline receptor agonist, identifies a novel adrenergic target for spinal analgesia
    Stone, LS
    Fairbanks, CA
    Wilcox, GL
    AGMATINE AND IMIDAZOLINES: THEIR NOVEL RECEPTORS AND ENZYMES, 2003, 1009 : 378 - 385
  • [33] A primate-dominant third glycosylation site of the β2-adrenergic receptor routes receptors to degradation during agonist regulation
    Mialet-Perez, J
    Green, SA
    Miller, WE
    Liggett, SB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (37) : 38603 - 38607
  • [34] Human β2-adrenergic receptor gene haplotypes and venodilation in vivo
    Bruck, H
    Leineweber, Y
    Park, J
    Weber, M
    Heusch, G
    Philipp, T
    Brodde, OE
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (03) : 232 - 238
  • [35] Investigation of allosteric communication pathways in human β2-adrenergic receptor
    Akdas, Basak
    Kurkcuoglu, Ozge
    Doruker, Pemra
    Akten, Demet
    PROTEIN SCIENCE, 2015, 24 : 142 - 143
  • [36] β1/β2-adrenergic receptor heterodimerization regulates β2-adrenergic receptor internalization and ERK signaling efficacy
    Lavoie, C
    Mercier, JF
    Salahpour, A
    Umapathy, D
    Breit, A
    Villeneuve, LR
    Zhu, WZ
    Xiao, RP
    Lakatta, EG
    Bouvier, M
    Hébert, TE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (38) : 35402 - 35410
  • [37] Moxonidine, a selective α2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice
    Fairbanks, CA
    Wilcox, GL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 290 (01): : 403 - 412
  • [38] β-arrestin binding to β2-adrenergic receptors requires both agonist occupancy and receptor phosphorylation
    Krasel, C
    Bünemann, M
    Lorenz, K
    Lohse, MJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R18 - R18
  • [39] Airway epithelial integrity is protected by a long-acting β2-adrenergic receptor agonist
    Coraux, C
    Kileztky, C
    Polette, M
    Hinnrasky, J
    Zahm, JM
    Devillier, P
    de Bentzmann, S
    Puchelle, E
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2004, 30 (05) : 605 - 612
  • [40] The effects of agonist stimulation and β2-adrenergic receptor level on cellular distribution of Gsα protein
    Can, A
    Sayar, K
    Friedman, E
    Ambrosio, C
    Erdemli, E
    Gurdal, H
    CELLULAR SIGNALLING, 2000, 12 (05) : 303 - 309